Marcus Tanaka

Marcus spent fourteen years on the IR side — six as Director of Investor Relations at a mid-cap industrial, four running IR for a healthcare growth-stage public company, and the past four advising boards and management teams through proxy seasons, activist campaigns, and contested transactions. The writing here is for the working IR professional and the corp-fin analyst who has to actually do the disclosure, prepare the earnings script, draft the proxy, and field the buy-side questions. It is not stock-picking content. It is not retail-investor content. It is trade writing about what IR work actually involves at the level of detail that practitioners need.

Page 23 of 29 · 340 articles total